Skip to search formSkip to main contentSkip to account menu

AV-299

Known as: SCH 900105 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

ficlatuzumab

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Abstract A55: Tumor-associated fibroblasts: A new target for cancer treatment
Head and neck squamous cell carcinoma (HNSCC) is an aggressive malignancy with a 50% rate of local failure with current standard… 
2013
2013
Severe refractory scarring alopecia associated with combinational use of ficlatuzumab (AV-299) and gefitinib.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)